Analyze Diet
Journal of veterinary pharmacology and therapeutics1995; 18(3); 187-195; doi: 10.1111/j.1365-2885.1995.tb00577.x

Pharmacokinetics of ketoprofen in healthy horses and horses with acute synovitis.

Abstract: The pharmacokinetic properties of a single intravenous dose of ketoprofen (2.2 mg/kg) in plasma and synovial fluid were compared in four healthy animals and four horses with experimentally induced acute synovitis. Synovitis was induced by the injection of a 1% solution of sterile carrageenan into the left intercarpal joint. Ketoprofen was administered at the same time as carrageenan infection. The plasma disposition followed a biexponential equation or a two-compartment model in most horses. The plasma harmonic mean half-life in healthy horses (0.88 h) was longer than in horses with synovitis (0.55 h). Synovial fluid concentrations of ketoprofen in healthy horses approximated those in plasma by 3 h post-dose. In horses with synovitis, synovial fluid concentrations approximated plasma concentrations by 1 h. Synovial fluid concentrations of ketoprofen in horses with synovitis were 6.5 times higher than those in healthy horses at 1 h. The area under the synovial fluid concentration curve for horses with synovitis was greater than in healthy horses. These data suggest that the inflamed joint serves as a site of sequestration for ketoprofen. Furthermore, these results indicate that plasma pharmacokinetics may be altered by inflammation in a peripheral compartments such as the joint.
Publication Date: 1995-06-01 PubMed ID: 7674454DOI: 10.1111/j.1365-2885.1995.tb00577.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research looked at how a painkiller called ketoprofen, administered through injection, is processed in the bodies of healthy horses vs those with acute synovitis—a painful joint condition. The study found that inflammation caused by this condition might affect how the painkiller is distributed and utilized in the body.

Study Overview

  • The experiment was conducted on eight horses—four healthy and four with acute synovitis, a condition induced by injecting the horses with a sterile carrageenan solution.
  • Ketoprofen, a non-steroidal anti-inflammatory drug commonly used for pain relief, was intravenously administered simultaneously with the carrageenan injection.
  • Scientists used a two-compartment model to understand the disposition of ketoprofen in the plasma.
  • The half-life and concentrations of ketoprofen in the plasma and synovial fluid were the primary focus of the study.

Key Findings

  • The researchers discovered that ketoprofen’s half-life was longer in healthy horses (0.88 hours) compared to horses with synovitis (0.55 hours).
  • In healthy horses, the drug’s concentrations in the synovial fluid approximated the plasma concentrations at 3 hours post-administration.
  • For synovitis-affected horses, synovial fluid and plasma concentrations of ketoprofen were almost identical just 1 hour after the drug was given.
  • Also at 1 hour, synovitis-affected horses had synovial fluid concentrations of ketoprofen that were 6.5 times higher than the healthy ones.

Implications

  • These findings suggest that inflammation in the joint, such as that seen in synovitis, could serve as a ‘trap’ for ketoprofen, causing higher concentrations of the drug in the joint space than in the rest of the body.
  • The data also indicates that inflammation might significantly change the plasma pharmacokinetics of the drug – which is how the body absorbs, distributes, metabolises, and excretes it.
  • This information could be critical in adjusting dosage and timings for painkiller administration in horses afflicted with joint inflammation, thereby ensuring optimal drug efficacy and minimising potential side effects.

Cite This Article

APA
Owens JG, Kamerling SG, Barker SA. (1995). Pharmacokinetics of ketoprofen in healthy horses and horses with acute synovitis. J Vet Pharmacol Ther, 18(3), 187-195. https://doi.org/10.1111/j.1365-2885.1995.tb00577.x

Publication

ISSN: 0140-7783
NlmUniqueID: 7910920
Country: England
Language: English
Volume: 18
Issue: 3
Pages: 187-195

Researcher Affiliations

Owens, J G
  • Department of Veterinary Physiology, Pharmacology and Toxicology, School of Veterinary Medicine, Louisiana State University, Baton Rouge 70803, USA.
Kamerling, S G
    Barker, S A

      MeSH Terms

      • Acute Disease
      • Animals
      • Carrageenan
      • Female
      • Half-Life
      • Horse Diseases / chemically induced
      • Horse Diseases / metabolism
      • Horses / metabolism
      • Injections, Intravenous / veterinary
      • Ketoprofen / administration & dosage
      • Ketoprofen / blood
      • Ketoprofen / pharmacokinetics
      • Male
      • Synovial Fluid / metabolism
      • Synovitis / chemically induced
      • Synovitis / metabolism
      • Synovitis / veterinary

      Citations

      This article has been cited 4 times.
      1. Mercer MA, Davis JL, McKenzie HC. The Clinical Pharmacology and Therapeutic Evaluation of Non-Steroidal Anti-Inflammatory Drugs in Adult Horses.. Animals (Basel) 2023 May 10;13(10).
        doi: 10.3390/ani13101597pubmed: 37238029google scholar: lookup
      2. Flood J, Stewart AJ. Non-Steroidal Anti-Inflammatory Drugs and Associated Toxicities in Horses.. Animals (Basel) 2022 Oct 26;12(21).
        doi: 10.3390/ani12212939pubmed: 36359062google scholar: lookup
      3. Lemonnier LC, Thorin C, Meurice A, Dubus A, Touzot-Jourde G, Couroucé A, Leroux AA. Comparison of Flunixin Meglumine, Meloxicam and Ketoprofen on Mild Visceral Post-Operative Pain in Horses.. Animals (Basel) 2022 Feb 21;12(4).
        doi: 10.3390/ani12040526pubmed: 35203234google scholar: lookup
      4. Donnell JR, Frisbie DD. Use of firocoxib for the treatment of equine osteoarthritis.. Vet Med (Auckl) 2014;5:159-168.
        doi: 10.2147/VMRR.S70207pubmed: 32670856google scholar: lookup